XOMA Co. (NASDAQ:XOMAP – Get Free Report) shares traded down 1.5% on Monday . The stock traded as low as $26.24 and last traded at $26.24. 3,524 shares were traded during trading, an increase of 85% from the average session volume of 1,905 shares. The stock had previously closed at $26.63.
XOMA Price Performance
The business’s 50-day moving average price is $26.65 and its 200 day moving average price is $26.29.
XOMA Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5391 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.16 annualized dividend and a dividend yield of 8.2%.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
- Five stocks we like better than XOMA
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
